Biotech News
Legend Biotech Reports Third Quarter 2026 Results and Recent Highlights
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported its third quarter 2026 unaudited financial results and recent highlights.
